-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
DMK PHARMACEUTICALS Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- DMK PHARMACEUTICALS Corp Operating Income (Loss) for the quarter ending September 30, 2023 was -$3.27M, a 29.4% increase year-over-year.
- DMK PHARMACEUTICALS Corp Operating Income (Loss) for the twelve months ending September 30, 2023 was -$25.3M, a 11.7% increase year-over-year.
- DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2022 was -$25.1M, a 21.9% increase from 2021.
- DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2021 was -$32.1M, a 11.8% increase from 2020.
- DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2020 was -$36.3M, a 23.8% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)